Previous close | 8.65 |
Open | 8.75 |
Bid | 8.66 x 1000 |
Ask | 8.67 x 800 |
Day's range | 8.42 - 8.79 |
52-week range | 5.55 - 17.85 |
Volume | |
Avg. volume | 703,766 |
Market cap | 715.041M |
Beta (5Y monthly) | 0.98 |
PE ratio (TTM) | N/A |
EPS (TTM) | -0.65 |
Earnings date | 08 Aug 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | 16.00 |
Viewing insider transactions for Paragon 28, Inc.'s ( NYSE:FNA ) over the last year, we see that insiders were net...
ENGLEWOOD, Colo., July 17, 2024--Paragon 28, Inc. (NYSE: FNA) ("PARAGON"), a leading medical device company exclusively focused on the foot and ankle orthopedic market, announced it will report financial results for the second quarter 2024 after market close on Thursday, August 8, 2024. The Company’s management will webcast a corresponding conference call beginning at 4:30 p.m. Eastern Time / 2:30 p.m. Mountain Time.
Paragon 28, Inc. (NYSE:FNA) Q1 2024 Earnings Call Transcript May 11, 2024 Paragon 28, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good afternoon. And welcome to Paragon 28’s First Quarter 2024 Earnings Conference Call. Currently, participants are in […]